Hospitals reduced central line-associated bloodstream infections by 50% between 2008 and 2016, according to a new progress summary by the Centers for Disease Control and Prevention. The report also shows progress by hospitals in reducing other healthcare-associated infections, including catheter-associated urinary tract, surgical site, methicillin-resistant staphylococcus aureus and Clostridium difficile infections. The AHA’s Health Research & Educational Trust affiliate has been working with the CDC to reduce CLABSI, CAUTI, C difficile and MRSA infections in targeted acute care hospitals. HRET also has worked with the Agency for Healthcare Research and Quality’s Comprehensive Unit Based Safety Program to prevent CLABSI and CAUTI infections, and with the Centers for Medicare & Medicaid Services’ Hospital Improvement Innovation Networks to continue to reduce hospital-acquired conditions in the Medicare program.

Related News Articles

Headline
The Centers for Medicare…
Headline
The AHA’s Institute for Diversity and Health Equity today named Duane Elliott Reynolds as its new president and CEO.
Blog
Axios' The poor state of U.S hospital quality (December 1, 2018) gives an incomplete view on the state of quality and safety in America’s hospitals and health…
Headline
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Jan. 2 to review confidential provider reports based on quality data from second-…
Headline
The Institute for Healthcare Improvement today released a white paper intended to help health system boards assess and improve their quality oversight…